Oxford University Innovation names Adam Stoten as new Chief Operating Officer
Dr Adam Stoten, the current Head of Technology Transfer Life Sciences at Oxford University Innovation (OUI), will be taking up the position of Chief Operating Officer (COO) at the University’s research commercialisation company from 1 April 2017. Adam has been a leading figure at OUI since 2005 when he joined the company as a Project Manager.
In 2010, he joined the Oxford-Emergent Tuberculosis Consortium, a joint venture between Oxford University and Emergent BioSolutions, which conducted the first ever efficacy study of a new tuberculosis vaccine in infants. He remained with the spinout until 2013 as its Deputy General Manager, before returning to OUI to head up its life sciences commercialisation activities.
Adam will take over from Linda Naylor, who retires at the end of April, having been with OUI since 2002. The COO position will replace Linda’s current title of Managing Director. Find out more